Chemomab Therapeutics Stock Forum

$Chemomab Therapeutics (CMMB.US)$ let it rip

$Chemomab Therapeutics (CMMB.US)$
The FDA's agreement to Chemomab's innovative Phase 3 trial design for nebokitug represents a groundbreaking development in PSC drug development. This is the first time the FDA has accepted clinical events as primary endpoints for PSC treatment approval, marking a paradigm shift from traditional approaches that relied heavily on surrogate markers and liver biopsies.
The streamlined approval pathway through a single Phase 3 trial has seve...

$Chemomab Therapeutics (CMMB.US)$
FDA Fast-Tracks Revolutionary PSC Drug: Single Phase 3 Trial Could Change Rare Disease Treatment

$Chemomab Therapeutics (CMMB.US)$ Reuters· 4 mins ago
Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns With FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (Cm-101) in Primary Sclerosing Cholangitis

$Chemomab Therapeutics (CMMB.US)$
Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis
Chemomab Therapeutics presented Phase 2 SPRING trial data for CM-101 in primary sclerosing cholangitis (PSC) at AASLD The Liver Meeting® 2024.
The trial, involving 76 patients, tested two doses (10 mg/kg and 20 mg/kg) administered every three weeks over 15 w...

$Chemomab Therapeutics (CMMB.US)$ Let buy some..

$Chemomab Therapeutics (CMMB.US)$ Reuters
1 min ago
Chemomab Therapeutics Announces Late-Breaking Oral Presentation of Cm-101 Phase 2 Results in Primary Sclerosing Cholangitis at Aasld the Liver Meeting® 2024

$Chemomab Therapeutics (CMMB.US)$ mmmm wat happen to the conference on 7 oct. seems so quiet here